Literature DB >> 31189557

Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Amee R Manges1, Hyun Min Geum2, Alice Guo2, Thaddeus J Edens3, Chad D Fibke2, Johann D D Pitout4,5.   

Abstract

Extraintestinal pathogenic Escherichia coli (ExPEC) strains are responsible for a majority of human extraintestinal infections globally, resulting in enormous direct medical and social costs. ExPEC strains are comprised of many lineages, but only a subset is responsible for the vast majority of infections. Few systematic surveillance systems exist for ExPEC. To address this gap, we systematically reviewed and meta-analyzed 217 studies (1995 to 2018) that performed multilocus sequence typing or whole-genome sequencing to genotype E. coli recovered from extraintestinal infections or the gut. Twenty major ExPEC sequence types (STs) accounted for 85% of E. coli isolates from the included studies. ST131 was the most common ST from 2000 onwards, covering all geographic regions. Antimicrobial resistance-based isolate study inclusion criteria likely led to an overestimation and underestimation of some lineages. European and North American studies showed similar distributions of ExPEC STs, but Asian and African studies diverged. Epidemiology and population dynamics of ExPEC are complex; summary proportion for some STs varied over time (e.g., ST95), while other STs were constant (e.g., ST10). Persistence, adaptation, and predominance in the intestinal reservoir may drive ExPEC success. Systematic, unbiased tracking of predominant ExPEC lineages will direct research toward better treatment and prevention strategies for extraintestinal infections.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Escherichia coli; extraintestinal infections; extraintestinal pathogenic E. coli; molecular epidemiology

Mesh:

Year:  2019        PMID: 31189557      PMCID: PMC6589867          DOI: 10.1128/CMR.00135-18

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  204 in total

1.  The epidemiology of nonenteric Escherichia coli infections: prevalence of serological groups.

Authors:  M TURCK; R G PETERSDORF
Journal:  J Clin Invest       Date:  1962-09       Impact factor: 14.808

2.  Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe.

Authors:  C Pomba; L López-Cerero; M Bellido; L Serrano; A Belas; N Couto; P Cavaco-Silva; J Rodríguez-Baño; A Pascual
Journal:  J Antimicrob Chemother       Date:  2013-09-10       Impact factor: 5.790

3.  Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients - an unrecognized CF pathogen?

Authors:  Petra Barillova; Veronika Tchesnokova; Angelika Dübbers; Peter Küster; Georg Peters; Ulrich Dobrindt; Evgeni V Sokurenko; Barbara C Kahl
Journal:  Int J Med Microbiol       Date:  2014-02-19       Impact factor: 3.473

4.  Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.

Authors:  Young Eun Ha; Cheol-In Kang; Min Kyeong Cha; So Yeon Park; Yu Mi Wi; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  Int J Antimicrob Agents       Date:  2013-09-07       Impact factor: 5.283

5.  Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanghai, China, 2011-2013.

Authors:  Sheng-Yuan Zhao; Yan-Chun Wang; Shu-Zhen Xiao; Xiao-Fei Jiang; Xiao-Kui Guo; Yu-Xing Ni; Li-Zhong Han
Journal:  Infect Dis (Lond)       Date:  2015-02-24

6.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

7.  Extended-spectrum β-lactamase-producing enterobacteriaceae among travelers from the Netherlands.

Authors:  Sunita Paltansing; Jessica A Vlot; Margriet E M Kraakman; Romy Mesman; Marguerite L Bruijning; Alexandra T Bernards; Leo G Visser; Karin Ellen Veldkamp
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

8.  Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial -Escherichia coli infection in China.

Authors:  Huiqing Shi; Fengjun Sun; Jianhong Chen; Qianyi Ou; Wei Feng; Xiaolan Yong; Peiyuan Xia
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-01-16       Impact factor: 3.944

9.  Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.

Authors:  Patrick Musicha; Nicholas A Feasey; Amy K Cain; Teemu Kallonen; Chrispin Chaguza; Chikondi Peno; Margaret Khonga; Sarah Thompson; Katherine J Gray; Alison E Mather; Robert S Heyderman; Dean B Everett; Nicholas R Thomson; Chisomo L Msefula
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

10.  Extraintestinal pathogenic Escherichia coli O1:K1:H7/NM from human and avian origin: detection of clonal groups B2 ST95 and D ST59 with different host distribution.

Authors:  Azucena Mora; Cecilia López; Ghizlane Dabhi; Miguel Blanco; Jesús E Blanco; María Pilar Alonso; Alexandra Herrera; Rosalía Mamani; Stéphane Bonacorsi; Maryvonne Moulin-Schouleur; Jorge Blanco
Journal:  BMC Microbiol       Date:  2009-07-07       Impact factor: 3.605

View more
  96 in total

Review 1.  Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options.

Authors:  Gisele Peirano; Johann D D Pitout
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

2.  Escherichia coli sequence type 73 bloodstream infections in a centralized Canadian region and their association with companion animals: an ecological study.

Authors:  Diego Nobrega; Gisele Peirano; Johann D D Pitout
Journal:  Infection       Date:  2022-06-03       Impact factor: 3.553

Review 3.  Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147.

Authors:  Gisele Peirano; Liang Chen; Barry N Kreiswirth; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

4.  Escherichia coli Sequence Type 457 Is an Emerging Extended-Spectrum-β-Lactam-Resistant Lineage with Reservoirs in Wildlife and Food-Producing Animals.

Authors:  Steven P Djordjevic; Monika Dolejska; Kristina Nesporova; Ethan R Wyrsch; Adam Valcek; Ibrahim Bitar; Khin Chaw; Patrick Harris; Jaroslav Hrabak; Ivan Literak
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

5.  OXA-181-Producing Extraintestinal Pathogenic Escherichia coli Sequence Type 410 Isolated from a Dog in Portugal.

Authors:  Michael Brilhante; Juliana Menezes; Adriana Belas; Claudia Feudi; Stefan Schwarz; Constança Pomba; Vincent Perreten
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

6.  Phylogenetic background and habitat drive the genetic diversification of Escherichia coli.

Authors:  Marie Touchon; Amandine Perrin; Jorge André Moura de Sousa; Belinda Vangchhia; Samantha Burn; Claire L O'Brien; Erick Denamur; David Gordon; Eduardo Pc Rocha
Journal:  PLoS Genet       Date:  2020-06-12       Impact factor: 5.917

7.  Temporal Trend of ST131 Clone among Urinary Escherichia coli Isolates in the Community: A Taiwan National Surveillance from 2002 to 2016.

Authors:  Jiun-Ling Wang; Wen-Chien Ko; Chih-Hsin Hung; Ming-Fang Cheng; Hui-Ying Wang; Yih-Ru Shiau; Jui-Fen Lai; I-Wen Huang; Li-Yun Hsieh; Tsai-Ling Yang Lauderdale
Journal:  Microorganisms       Date:  2021-04-29

8.  Extended-Spectrum β-Lactamase-Producing and mcr-1-Positive Escherichia coli from the Gut Microbiota of Healthy Singaporeans.

Authors:  Yichen Ding; Woei-Yuh Saw; Linda Wei Lin Tan; Don Kyin Nwe Moong; Niranjan Nagarajan; Yik Ying Teo; Henning Seedorf
Journal:  Appl Environ Microbiol       Date:  2021-08-04       Impact factor: 4.792

9.  Genomic analysis of trimethoprim-resistant extraintestinal pathogenic Escherichia coli and recurrent urinary tract infections.

Authors:  Dmitriy Li; Cameron J Reid; Timothy Kudinha; Veronica M Jarocki; Steven P Djordjevic
Journal:  Microb Genom       Date:  2020-11-18

10.  Identity of blaCTX-M Carrying Plasmids in Sequential ESBL-E. coli Isolates from Patients with Recurrent Urinary Tract Infections.

Authors:  Nahid Karami; Sriram Kk; Shora Yazdanshenas; Yii-Lih Lin; Daniel Jaén-Luchoro; Elina Ekedahl; Sanjana Parameshwaran; Anna Lindblom; Christina Åhrén; Fredrik Westerlund
Journal:  Microorganisms       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.